What We're Reading: Page 132
Industry reads hand-picked by our editors
Jul 29, 2021
Jul 28, 2021
-
Bloomberg
NYC Brain Computer Startup Announces FDA Trial Before Elon Musk
-
360Dx
CDC to Withdraw EUA for COVID-19 Test; FDA Revokes Three Other EUAs for Non-Use, Agency Clearance
-
MobiHealthNews
LifeSignals lands FDA clearance for its remote monitoring wearable biosensor
-
TCTMD
Outpatient PCI Takes Hold in US Practice, Muddying Volume Trends
Jul 27, 2021
-
CNN
Debate emerges around Covid-19 testing strategies in schools as districts plan to reopen
-
STAT
Epic’s AI algorithms, shielded from scrutiny by a corporate firewall, are delivering inaccurate information on seriously ill patients
-
Kaiser Health News
The Pandemic Made Telemedicine an Instant Hit. Patients and Providers Feel the Growing Pains.
-
TCTMD
3M TAVR: Minimalist TAVI Pathway Saves Money
Jul 26, 2021
-
Wall Street Journal
PerkinElmer Buying Antibodies Maker BioLegend for $5.25 Billion
-
MedCity News
Would Illumina’s acquisition of GRAIL constrict the expansion of the liquid biopsy space?
-
MedPage Today
Surprising Tradeoffs of Valve-in-Valve TAVR vs Redo Surgery
-
Axios
A reality check on the GOP's push for coronavirus antibody testing